A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood
Clinical trial NCT05738291 · COMPLETED
Trial details
- NCT number
- NCT05738291
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-06-14
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.